Sign in to view content

Risk of Sight-Threatening Diabetic Retinopathy With GLP-1 RA Use: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide

Andrew J. Barkmeier, MD

Video
Published 2025

Related

Impact of Race on Vision Outcomes in Ranibizumab-Treated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trials
M. Ali Khan, MD, FACS, FASRS
Annual Meeting Talks
2021
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2019
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023

Category: Diabetic Retinopathy

See more